Want to see AVTR full AI Analyst Report?
Top Page
Avantor
(NYSE:AVTR)
Select Model
Select Model
Rating:64Neutral
Price Target:
$15.50
▲(31.80% Upside)
Action:Reiterated
Date:07/30/26
The score reflects a tug-of-war between weak recent profitability (major drag on financial performance) and improving operating narrative. Technically, the stock is in a strong uptrend versus key moving averages, and the earnings call was supportive with raised guidance and solid free cash flow expectations. Valuation is constrained by losses (negative P/E), keeping the overall score in the mid-range.
Positive Factors
Recurring, embedded consumables demand
Avantor's core model sells high-frequency consumables, reagents and lab supplies into regulated workflows. Qualification friction and bundled services create switching costs and recurring revenue, providing a durable, predictable revenue base across biopharma, healthcare and research markets.
Negative Factors
Deteriorated profitability / net losses
Large net losses over 2025 and TTM 2026 materially weaken returns on capital and shareholder equity. Persistent negative profitability constrains reinvestment, raises the hurdle to restore ROIC, and increases reliance on cash generation and structural margin fixes to return to sustainable earnings.
Read all positive and negative factors
Positive Factors
Negative Factors
Recurring, embedded consumables demand
Avantor's core model sells high-frequency consumables, reagents and lab supplies into regulated workflows. Qualification friction and bundled services create switching costs and recurring revenue, providing a durable, predictable revenue base across biopharma, healthcare and research markets.
Read all positive factors
Avantor Key Performance Indicators (KPIs)
Any
Revenue by Segment
Shows how much each business segment contributes to total revenue, indicating the company’s diversification and which segments are leading growth or facing headwinds.
Shows how much each business segment contributes to total revenue, indicating the company’s diversification and which segments are leading growth or facing headwinds.
Data provided by:
The Fly
The FlyAvantor (AVTR) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$9.82B
Dividend YieldN/A
Average Volume (3M)8.85M
Price to Earnings (P/E)―
Beta (1Y)0.91
Revenue Growth-1.57%
EPS Growth-183.83%
CountryUS
Employees13,500
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)-0.84
Shares Outstanding676,358,800
10 Day Avg. Volume10,970,589
30 Day Avg. Volume8,850,736
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)1.40
Price to Sales (P/S)1.19
P/FCF Ratio15.70
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$12.50Price Target Upside6.29% Upside
Rating ConsensusHold
Number of Analyst Covering14
EPS Forecast (FY)0.81
Revenue Forecast (FY)$6.58B
Avantor Business Overview & Revenue Model
Company Description
Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services. Operating across the Americas, Europe, Asia, the Middle East, and Africa, Avantor caters to a wide arr...
How the Company Makes Money
Avantor primarily makes money by selling products and services that are repeatedly used in laboratory and bioprocessing workflows and are embedded in customers’ ongoing operations. (1) Product sales: A substantial portion of revenue comes from rec...
Avantor Earnings Call Summary
Earnings Call Date:Jul 29, 2026
(Q2-2026)
| % Change Since: |
Next Earnings Date:Oct 23, 2026
Earnings Call Sentiment Positive
The call conveyed tangible operational progress and improving commercial momentum, highlighted by VWR's return to organic growth, strong free cash flow generation, measurable Revival-driven productivity gains, and raised full-year guidance. These positives are balanced against near-term headwinds in the BMP segment from discrete order normalization, ongoing inflationary and FX pressures, and leverage that remains above the company's target. Management expressed confidence in accelerating growth into the second half and into 2027, supported by order momentum and execution improvements.Positive Updates
Revenue and Top-Line Performance
Q2 revenue of $1.69 billion; reported revenue up 0.5% year-over-year while organic revenue declined 0.4%. VWR Distribution & Services grew 1.7% organically in Q2 and drove better-than-expected top-line results.
Negative Updates
Organic Revenue Pressure Consolidated
Consolidated organic revenue declined 0.4% in Q2, reflecting mixed end-market dynamics and discrete order normalization in some BMP businesses.
Read all updates
Q2-2026 Updates
Positive
Negative
Revenue and Top-Line Performance
Q2 revenue of $1.69 billion; reported revenue up 0.5% year-over-year while organic revenue declined 0.4%. VWR Distribution & Services grew 1.7% organically in Q2 and drove better-than-expected top-line results.
Read all positive updates
Company Guidance
Avantor raised its 2026 outlook, now expecting organic revenue growth of -0.5% to +0.5%, adjusted EPS of $0.80–$0.83 and free cash flow of $500–$550 million (Q2 FCF was $143M, $152M excl. restructuring), while keeping adjusted EBITDA margin guidance unchanged; Q3 EPS is guided to $0.20–$0.21 assuming ~250 basis points of company organic growth in Q3, FX headwinds of about 125 bps to Q3 reported revenue and ~50 bps to full‑year reported revenue, a weighted average diluted share count of ~677 million, and modestly lower net interest expense vs. 2025. Management reiterated that VWR should accelerate sequentially (VWR was +1.7% organic in Q2) and BMP should return to growth in H2 (BMP was -5.6% organic in Q2), noted BMP facing discrete headwinds of ~150 bps in Q3 and ~400 bps in Q4 in electronic materials, and emphasized capital allocation priorities: continue investing for growth, target adjusted net leverage below 3x (ended Q2 at 3.3x with $3.4B net debt after $112M debt repayment in Q2 and nearly $500M repaid over the trailing 12 months).Avantor Financial Statement Overview
Summary
Income Statement
36
Negative
Balance Sheet
58
Neutral
Cash Flow
63
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.56B | 6.55B | 6.78B | 6.97B | 7.51B | 7.39B |
| Gross Profit | 2.09B | 2.14B | 2.28B | 2.36B | 2.60B | 2.50B |
| EBITDA | 19.70M | 138.70M | 1.48B | 1.10B | 1.52B | 1.35B |
| Net Income | -578.00M | -530.20M | 711.50M | 321.10M | 686.50M | 572.60M |
Balance Sheet | ||||||
| Total Assets | 11.60B | 11.79B | 12.11B | 12.97B | 13.46B | 13.90B |
| Cash, Cash Equivalents and Short-Term Investments | 306.80M | 365.40M | 261.90M | 262.90M | 372.90M | 301.70M |
| Total Debt | 37.00M | 3.95B | 4.06B | 5.54B | 6.29B | 7.02B |
| Total Liabilities | 5.97B | 6.23B | 6.16B | 7.72B | 8.61B | 9.70B |
| Stockholders Equity | 5.63B | 5.57B | 5.96B | 5.25B | 4.86B | 4.20B |
Cash Flow | ||||||
| Free Cash Flow | 288.40M | 495.00M | 692.00M | 723.60M | 710.20M | 842.50M |
| Operating Cash Flow | 436.20M | 623.80M | 840.80M | 870.00M | 843.60M | 953.60M |
| Investing Cash Flow | -148.40M | -130.50M | 438.90M | -143.70M | -109.60M | -4.12B |
| Financing Cash Flow | -420.70M | -409.40M | -1.28B | -843.70M | -648.70M | 3.22B |
Avantor Technical Analysis
Positive
11.76
Price Trends
10.05
Positive
9.01
Positive
10.23
Positive
Market Momentum
0.46
Negative
65.80
Neutral
71.29
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AVTR, the sentiment is Positive. The current price of 11.76 is above the 20-day moving average (MA) of 11.24, above the 50-day MA of 10.05, and above the 200-day MA of 10.23, indicating a bullish trend. The MACD of 0.46 indicates Negative momentum. The RSI at 65.80 is Neutral, neither overbought nor oversold. The STOCH value of 71.29 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AVTR.
Avantor Risk Analysis
Avantor disclosed 39 risk factors in its most recent earnings report. Avantor reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Avantor Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $7.69B | 19.52 | 6.77% | 4.91% | -7.41% | -56.10% | |
64 Neutral | $9.82B | -15.45 | -10.34% | ― | -1.57% | -183.83% | |
60 Neutral | $2.58B | 531.00 | 7.12% | 1.34% | 6.25% | -94.37% | |
56 Neutral | $13.43B | -33.28 | -2.35% | 1.41% | 7.87% | 69.44% | |
56 Neutral | $18.56B | 23.24 | 14.69% | 1.48% | 18.36% | 35.24% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | $9.26B | -5.66 | -17.68% | 2.87% | -8.63% | -524.43% |
* Healthcare Sector Average
AVTR
Avantor
13.86
2.50
22.01%
ALB
Albemarle
117.76
50.77
75.78%
EMN
Eastman Chemical
70.07
14.07
25.12%
KWR
Quaker Chemical
154.92
38.68
33.28%
SQM
Sociedad Quimica Y Minera SA
68.43
32.89
92.55%
WLK
Westlake Corporation
71.72
-1.76
-2.40%
Avantor Corporate Events
Executive/Board ChangesShareholder Meetings
Avantor Shareholders Approve Proposals at 2026 Annual Meeting
Positive
May 12, 2026
Avantor, Inc. held its 2026 Annual Meeting of Stockholders on May 7, 2026, where shareholders elected nine directors to one-year terms ending at the 2027 annual meeting and approved, on an advisory basis, the 2025 compensation of the company’...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.